Pri-Med Podcasts
A primary care podcast featuring expert faculty discussing the most recent developments in the medical field. Podcast formats include, but are not limited to: expert clinical discussions, frequently asked questions, and Frankly Speaking About Family Medicine with Dr. Frank Domino. Many Pri-Med Podcasts are available for CME Credit! For CME podcasts, find the link to claim credit in those episodes’ descriptions or find the episode on our Pri-Med Podcast landing page, www.pri-med.com/podcast
Episodes
Monday Jan 02, 2023
Monday Jan 02, 2023
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-309
Overview: Listen to this podcast to get answers to important questions about vitamin D supplementation in the first year of life. We will review a recent systematic review and meta-analysis on the relationship between vitamin D supplementation in the first year of life and outcomes, and we will discuss how these findings can be applied to your practice.
Episode resource links:
Nutrients; 2021 Feb 5;13(2):524. doi: 10.3390/nu13020524
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Monday Dec 26, 2022
Monday Dec 26, 2022
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-308
Overview: In this episode, each podcaster will discuss the most impactful paper and podcast of the year.
Episode resource links:
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-299
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-275
https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-268
Guest: Alan Ehrlich MD, FAAFP, Jillian Joseph, MPAS, PA-C, Susan Feeney, DNP, FNP-BC, NP-C, Mariyan L. Montaque, DNP, FNP-BC, Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Monday Dec 19, 2022
Monday Dec 19, 2022
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-307
Overview: The COVID-19 epidemic resulted in overflowing ICUs and significant numbers of deaths among older adults. A recent study looked at the differences in outcomes between patients admitted with “No-code” vs “CPR” status and found no difference for high-risk individuals. Listen to this brief podcast to explore the data from this study and, in turn, give patients the information they need to make informed decisions regarding their desired code status on their advanced directives.
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Thursday Dec 15, 2022
Thursday Dec 15, 2022
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/case-study-traditional-migraine-treatment
Overview:
This podcast will focus on the case of a patient with a 30-year history of migraine who has tried numerous acute and preventive treatments. Faculty will discuss newer treatment options, including calcitonin gene-related peptide (CGRP) receptor antagonists (gepants), CGRP monoclonal antibodies, ditans, and neuromodulation.
Thursday Dec 15, 2022
Thursday Dec 15, 2022
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/migraine-treatment-questions-answered
Overview:
In this podcast, Drs. Dawn Buse and Michael Ready will address questions about migraine treatment posed by Pri-Med learners during recent programs. Topics will include the proper use of calcitonin gene-related peptide (CGRP) monoclonal antibodies, nutraceuticals, acupuncture, and tetrahydrocannabinol.
Monday Dec 12, 2022
Monday Dec 12, 2022
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-306
Overview: In 2015, a landmark study, LEAP (Learning Early About Peanut Allergy), found that early introduction to peanuts, at 4 to 6 months, significantly reduced the incidence of peanut allergies in all children but especially in those at high risk for allergies. A recent survey of pediatric residents and attendings in a large academic center regarding knowledge and implementation of the guidelines uncovered a significant knowledge gap impacting the health of children. Join us as we discuss this gap and review the guidelines for preventing peanut allergies in infants and children.
Episode resource links:
Sandhu S, Hanono M, Nagarajan S, Vastardi MA. Knowledge assessment of early peanut introduction in a New York City population [published online ahead of print, 2022 Jun 18]. Ann Allergy Asthma Immunol. 2022;S1081-1206(22)00534-8. doi:10.1016/j.anai.2022.06.013
Greer FR, Sicherer SH, Burks AW, AAP COMMITTEE ON NUTRITION, AAP SECTION ON ALLERGY AND IMMUNOLOGY. The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. Pediatrics. 2019;143(4): e20190281
Togias A, Cooper SF, Acebal ML, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. Ann Allergy Asthma Immunol. 2017;118(2):166-173.e7. doi:10.1016/j.anai.2016.10.004
Fleischer DM, Sicherer S, Greenhawt M, et al. Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants. Pediatr Dermatol. 2016;33(1):103-106. doi:10.1111/pde.12685
Du Toit, G., Roberts, G., Sayre, P. H., Bahnson, H. T., Radulovic, S., Santos, A. F., Brough, H. A., Phippard, D., Basting, M., Feeney, M., Turcanu, V., Sever, M. L., Gomez Lorenzo, M., Plaut, M., Lack, G., & LEAP Study Team (2015). Randomized trial of peanut consumption in infants at risk for peanut allergy. The New England journal of medicine, 372(9), 803–813. https://doi.org/10.1056/NEJMoa1414850
Koplin JJ, Soriano VX, Peters RL. Real-World LEAP Implementation. Curr Allergy Asthma Rep. 2021;22(6):61-66. doi:10.1007/s11882-022-01032-3
https://www.fda.gov/food/cfsan-constituent-updates/fda-completes-review-notification-regarding-health-claim-related-peanut-allergies
Guest: Susan Feeney, DNP, FNP Music Credit: Richard Onorato
Monday Dec 05, 2022
Monday Dec 05, 2022
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-305
Overview: We will review the general treatment approach to gastroesophageal reflux disease (GERD) and the risks of using proton pump inhibitors (PPI) for long durations. In particular, we will examine a new study that links PPI use, in comparison with H2 receptor antagonist (H2RA) use, with a significant increase in the risk of gastric cancer. This episode will highlight the importance of looking at PPIs on a medication review and evaluating whether patients are taking them for longer than needed.
Episode resource links:
Abrahami D, McDonald EG, Schnitzer ME, et al. Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut. 2022;71(1):16-24.
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato
Wednesday Nov 30, 2022
Wednesday Nov 30, 2022
Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/agitation-in-alzheimers-dementia
Overview: Agitation is among the most common behavioral symptoms among patient with dementia, including Alzheimer’s dementia. It exacts a significant burden on patients because it is associated with not only greater morbidity and mortality, but also a faster cognitive and functional decline. It is also a leading predictor of which individuals with dementia will be transferred to residential care. This podcast provides an overview of the epidemiology, causes, and the burden of agitation in patients with Alzheimer’s dementia.
Monday Nov 28, 2022
Monday Nov 28, 2022
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304
Overview: Pharmacogenomic testing has been suggested as a way to personalize medicine, particularly where the metabolism of medications can vary significantly. Unfortunately, despite increasing use of this testing, there has been little evidence showing a benefit in clinical outcomes. Listen to this podcast to explore the data on clinical outcomes for pharmacogenetic testing and how to best select medication for patients with depression.
Episode resource links:
Oslin DW, Lynch KG, Shih MC, et al. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022;328(2):151-161.
Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Monday Nov 21, 2022
Monday Nov 21, 2022
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-303
Overview: Millions of Americans take Vitamin D supplementation to prevent a variety of illnesses, from COVID-19 and osteoporosis to heart disease and cancer. While most studies have failed to show a benefit in preventing COVID-19, heart disease, and cancer, the evidence has been mixed, at best, in showing benefits for preventing bone fractures. Despite this, vitamin D supplementation remains popular for fracture prevention. Join us to review a study published in the New England Journal of Medicine that failed to find any benefits for preventing fractures.
Episode resource links:
N Engl J Med 2022;387:299-309. DOI: 10.1056/NEJMoa2202106
Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato